Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
US7157079B2 · kind B2 · utility
22Cited by
5References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 13, 2004 |
| Grant date | Jan 2, 2007 |
| Priority date | — |
| Expiry date | May 31, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2799/022
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
In one embodiment, this invention provides methods of treating mammalian cancer or hyperproliferative cells, said method comprising contacting said cells with a tumor suppressor protein or tumor suppressor nucleic acid and also contacting said cell with at least one adjunctive anti-cancer agent. The invention also provides for a pharmacological composition comprising a tumor suppressor protein or a tumor suppressor nucleic acid and at least one adjunctive anti-cancer agent, and a kit for the treatment of mammalian cancer or hyperproliferative cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.